172 related articles for article (PubMed ID: 30353682)
1. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.
Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X
J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682
[TBL] [Abstract][Full Text] [Related]
2. Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women.
Yi J; Jin H; Zhang R; Zhang S; Chen P; Yu X; Zhang X
J Endocrinol Invest; 2018 Jun; 41(6):663-670. PubMed ID: 29151239
[TBL] [Abstract][Full Text] [Related]
3. Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population.
Zhang S; Chen P; Jin H; Yi J; Xie X; Yang M; Gao T; Yang L; Hu C; Zhang X; Yu X
Sci Rep; 2017 Jun; 7(1):3114. PubMed ID: 28596534
[TBL] [Abstract][Full Text] [Related]
4. CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome.
Lankinen MA; Hanhineva K; Kolehmainen M; Lehtonen M; Auriola S; Mykkänen H; Poutanen K; Schwab U; Uusitupa M
PLoS One; 2015; 10(4):e0124379. PubMed ID: 25874636
[TBL] [Abstract][Full Text] [Related]
5. Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.
Amin RF; El Bendary AS; Ezzat SE; Mohamed WS
Diabetes Metab Syndr; 2019; 13(3):2226-2229. PubMed ID: 31235161
[TBL] [Abstract][Full Text] [Related]
6. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
7. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
8. Pure omega 3 polyunsaturated fatty acids (EPA, DPA or DHA) are associated with increased plasma levels of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) in a short-term study in women.
Liu G; Gibson RA; Callahan D; Guo XF; Li D; Sinclair AJ
Food Funct; 2020 Mar; 11(3):2058-2066. PubMed ID: 32142084
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
Suzuki Y; Sasamoto Y; Yoshijima C; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
J Pharm Biomed Anal; 2020 May; 184():113202. PubMed ID: 32114159
[TBL] [Abstract][Full Text] [Related]
10. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis.
Mohan H; Brandt SL; Kim JH; Wong F; Lai M; Prentice KJ; Al Rijjal D; Magomedova L; Batchuluun B; Burdett E; Bhattacharjee A; Cummins CL; Belsham DD; Cox B; Liu Y; Wheeler MB
Diabetes Obes Metab; 2019 Jan; 21(1):61-72. PubMed ID: 30062833
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial.
Zheng JS; Lin M; Imamura F; Cai W; Wang L; Feng JP; Ruan Y; Tang J; Wang F; Yang H; Li D
Sci Rep; 2016 Jul; 6():29522. PubMed ID: 27404516
[TBL] [Abstract][Full Text] [Related]
12. Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study.
Miao Z; Zeng FF; Tian Y; Xiao C; Yan Y; Jiang Z; Fu Y; Chen YM; Zheng JS
Am J Clin Nutr; 2023 Sep; 118(3):637-645. PubMed ID: 37482300
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
[TBL] [Abstract][Full Text] [Related]
14. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
[TBL] [Abstract][Full Text] [Related]
15. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
[TBL] [Abstract][Full Text] [Related]
17. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
18. Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
Luce M; Bouchara A; Pastural M; Granjon S; Szelag JC; Laville M; Arkouche W; Fouque D; Soulage CO; Koppe L
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29783628
[TBL] [Abstract][Full Text] [Related]
19. Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study.
Dallio M; Masarone M; Caprio GG; Di Sarno R; Tuccillo C; Sasso FC; Persico M; Loguercio C; Federico A
J Gastrointestin Liver Dis; 2017 Sep; 26(3):261-268. PubMed ID: 28922438
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-29b positively correlates with non-alcoholic fatty liver disease in a Chinese population.
He Z; Yang JJ; Zhang R; Li HT; Wu L; Jiang F; Jia WP; Hu C
J Dig Dis; 2019 Apr; 20(4):189-195. PubMed ID: 30756471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
